Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia,viral shedding and transmission of the virus in a quasi-natural experimental model

The present study assessed the efficacy of vaccination against genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) in terms of reduction of the transmission. Ninety-eight 3-week-old piglets were divided in two groups: V (n = 40) and NV (n = 58) that were housed separately. V animals were vaccinated with a commercial genotype 1 PRRSV vaccine while NV were kept as controls. On day 35 post-vaccination, 14 NV pigs were separated and inoculated intranasally with 2 ml of a heterologous genotype 1 PRRSV isolate (“seeder” pigs, SP). The other V and NV animals were distributed in groups of 5 pigs each. Two days later, one SP was introduced into each pen to expose V and NV to PRRSV. Sentinel pigs were allocated in adjacent pens. Follow-up was of 21 days. All NV (30/30) became viremic after contact with SP while only 53% of V pigs were detected so (21/40, p < 0.05). Vaccination shortened viremia (12.2 ± 4 versus 3.7 ± 3.4 days in NV and V pigs, respectively, p < 0.01). The 50% survival time for becoming infected (Kaplan–Meier) for V was 21 days (CI_95% = 14.1–27.9) compared to 7 days (CI_95% = 5.2–8.7) for NV animals (p < 0.01). These differences were reflected in the R value as well: 2.78 (CI_95% = 2.13–3.43) for NV and 0.53 (CI_95% = 0.19–0.76) for V pigs (p < 0.05). All sentinel pigs (10/10) in pens adjacent to NV + SP pens got infected compared to 1/4 sentinel pigs allocated contiguous to a V + SP pen. These data show that vaccination of piglets significantly decrease parameters related to PRRSV transmission.     

MTT法评价猪口蹄疫合成肽疫苗的细胞免疫应答

为评价猪口蹄疫合成肽疫苗免疫猪后的细胞免疫应答,用含有E、F两种多肽抗原的猪口蹄疫合成肽疫苗免疫猪,二免后两周采血分离猪外周血淋巴细胞,再用E、F两种合成肽及二者混合物对淋巴细胞刺激培养48 h,用MTT法检测特异性T淋巴细胞增殖反应。结果显示,在抗原E、F混合物浓度为50μg/mL时,抗原对免疫组淋巴结细胞的刺激增殖作用显著高于未免疫对照组（P〈0.01）。表明,该猪口蹄疫合成肽疫苗免疫猪能有效引起特异性T淋巴细胞免疫应答。     

鸭传染性浆膜炎疫苗的研究

用从浙江省分离鉴定的鸭疫里氏杆菌RA-J、RA-L菌株研制疫苗，采用改进的液体培养和鸭胚培养工艺，抗原含量分别达120-186亿CFU／ml和280-310CFU／ml，免疫0.5ml/只，2MLD强毒攻击，平均保护率达94.2％（48／52），免疫后第7天保护率达80％（16／20），10天达93.8％（15／16），疫苗在4℃-8℃条件下保存7个半月和1年的保护率达90％和85％。野外扩大试验和临床推广试用236万羽份表明，效果良好。     

灿烂弧菌灭活菌苗对美国红鱼免疫效果的研究

制备灿烂弧菌(Vibrio splendidus)福尔马林灭活菌苗,通过浸泡、注射和口服3种方式接种美国红鱼(Sci-aenops ocellatus),分别在接种免疫后第7、14、21、28、35天采鱼血,检测其血清抗体效价、溶菌酶活力和白细胞吞噬活性;第28天用1.0×108CFU/mL的灿烂弧菌悬液进行攻毒试验,检测菌苗的免疫效果。结果表明,各免疫组血清抗体效价在第21天达到峰值,且浸泡组和注射组的血清抗体效价高于口服组;在35d实验期内,各免疫组的血清溶菌酶活力有明显提高,各浸泡组和注射组于免疫接种后14d显著高于对照组(P<0.05);除浸泡3组外,其余各免疫组的白细胞吞噬百分比(PP)和吞噬指数(PI)在免疫接种后14d均较对照组有显著差异(P<0.05);各组受免鱼对人工攻毒均具有保护作用,以注射2组的免疫保护率最高,达77.8%。     

鸡马立克氏病双价疫苗的研究 Ⅰ.马立克氏病SB-1病毒株在鸡胚皮肤细胞中的培养试验

以简便技术制备鸡胚皮肤(CES)细胞,进而进行了鸡马立克氏病(MD)SB-1株病毒适应于CES细胞和致CES细胞病变效应(CPE)的研究.试验表明,在形成CPE的细胞中可检出核内包涵体,MD的SB-1株病毒的CES细胞毒的蚀斑形成单位(pfu)为105.7201-7.2122/m L.本研究为以后用CES细胞增殖SB-1株病毒以代替鸡胚成纤维细胞(CEF)制造疫苗提供了依据.     

鸡大肠杆菌灭活苗的研制及其应用

为预防鸡大肠杆菌病的发生,从武威地区发病鸡群分离的埃希氏大肠杆菌分离株经雏鸡毒力复壮后,于普通肉汤培养基中增菌培养,经甲醛灭活后制成灭活菌苗,通过实验室各项检验后免疫鸡群,经安全检验和效力检验证明该灭活菌苗安全有效。接种1月龄仔鸡可产生坚强免疫力,能有效预防仔鸡大肠杆菌病的发生。     

减毒鼠伤寒沙门氏菌载体在兽医疫苗中的运用

重组疫苗的研究中,减毒鼠伤寒沙门氏菌可以作为真核表达载体。其原理是将免疫原基因片段连接到某种真核质粒中,然后将质粒导入减毒鼠伤寒沙门氏菌,构建针对该特异病原的重组活疫苗。本文介绍了减毒鼠伤寒沙门氏菌作为DNA载体,在动物细菌、病毒和支原体重组活疫苗中的运用。     

弓形虫分子免疫学研究进展

弓形虫病是由刚第弓形虫引起的一种危害严重的全球性人兽共患寄生虫病,全世界各国学者对此原虫的研究十分重视,尤其是近年来对其免疫学的研究成果对深入了解该原虫的致病机理和进行有效的免疫预防非常重要。从宿主感染弓形虫后的免疫效应、免疫诊断及其疫苗等方面阐述了弓形虫分子免疫学研究进展。